AMED - Amedisys, Inc.
| Previous Close | 132.09 |
| Open | 131.84 |
| Bid | 135.21 x 800 |
| Ask | 135.35 x 1800 |
| Day's Range | 131.51 - 136.06 |
| 52 Week Range | 97.38 - 141.98 |
| Volume | 301,077 |
| Avg. Volume | 310,907 |
| Market Cap | 4.357B |
| Beta (3Y Monthly) | 1.31 |
| PE Ratio (TTM) | 35.91 |
| EPS (TTM) | 3.77 |
| Earnings Date | Oct 28, 2019 - Nov 1, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 145.36 |
- Zacks
QIAGEN (QGEN) Hurt by Low QuantiFERON-TB Sales & FX Headwind
Poor QuantiFERON-TB sales in Americas and an unfavourable currency translation affect QIAGEN's (QGEN) overall performance.
- Zacks
PRA Health Simplifies Treatment Decisions With Metys Launch
PRA Health (PRAH) expects to enhance position and capabilities in the data and analytics field with the new tool, while simplifying treatment decisions.
- Zacks
Here's Why You Should Retain Pacific Biosciences For Now
Pacific Biosciences (PACB) continues to gain from innovative product portfolio and Sequel system. However, contraction in gross margin remains a woe.
- Zacks
3 Reasons Why Growth Investors Shouldn't Overlook Amedisys (AMED)
Amedisys (AMED) possesses solid growth attributes, which could help it handily outperform the market.
- Zacks
Intersect ENT Rides on Innovation Amid Pricing Concerns
The SINUVA business line of Intersect ENT (XENT) makes a quick and remarkable progress with market access and field force balance.
- Zacks
HMS Holdings Acquires VitreosHealth, Boosts PHM Solution Set
HMS Holdings (HMSY) can leverage VitreosHealth's prescriptive health insights that will enhance its growing and lucrative PHM suite.
- Zacks
Here's Why You Should Retain OPKO Health (OPK) Stock For Now
OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and solid R&D focus. However, operating losses remain a woe.
- Zacks
Medtronic Collaborates With Novo Nordisk for Diabetes Care
This collaboration is expected to boost Medtronic's (MDT) diabetes management portfolio.
- Zacks
Add These 5 Stocks With Impressive Interest Coverage Ratio
Interest coverage ratio is used to determine how effectively a company can pay the interest charged on its debt.
- Zacks
DVA vs. AMED: Which Stock Should Value Investors Buy Now?
DVA vs. AMED: Which Stock Is the Better Value Option?
- Zacks
BioSig Technologies-Mayo Clinic Ink Electrophysiology Deal
This collaboration is expected to bolster BioSig's (BSGM) commitment toward offering higher quality patient care by introducing innovative technological solutions to medicine.
- Zacks
Here's Why You Should Hold on to Ecolab (ECL) Stock Now
Ecolab (ECL) continues to gain from robust product portfolio and strong international presence. However, forex remains a woe.
- Zacks
Bruker (BRKR) Introduces the nanoIR3-s Broadband System
The launch of the FTIR spectroscopy system complements Bruker's (BRKR) target to boost its portfolio of nanoIR products.
- Zacks
Integra Buys Rebound Therapeutics to Boost Neurosurgery Line
Integra (IART) believes, Rebound's MIS technological arm will widen its neurosurgical pipeline within Codman Specialty Surgical space.
- Zacks
Medtronic's (MDT) MiniMed 670G Gains German Reimbursement
Medtronic's (MDT) MiniMed 670G is witnessing a solid uptake in the United States ever since its launch last year.
- Zacks
Medtronic's (MDT) IN.PACT AV Access Study Results Bode Well
The results of the study will prove to be a major stride for Medtronic (MDT) to treat patient suffering from renal diseases.
- Zacks
Here's Why You Should Invest in Intuitive Surgical (ISRG) Now
Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base.
- Zacks
Masimo (MASI) Boosts O3 Platform With Three New Indices
Masimo (MASI) announced the development of three additional indices for O3 Regional Oximetry, thereby improving the O3 platform.
- Zacks
Here's Why You Should Retain NextGen Healthcare Stock Now
NextGen Healthcare (NXGN) is gaining traction from the U.S. RCM market and the growing EHR market. However, margin pressure remains a concern.
- Zacks
Here's Why You Should Invest in Amedisys (AMED) Right Now
Amedisys (AMED) is currently enjoying investors' confidence, thanks to solid prospects.
- Zacks
Here's Why You Should Invest in Integer Holdings (ITGR) Now
Integer Holdings (ITGR) continues to benefit from portfolio management, strong foothold in the broader MedTech space and rising Non-Medical sales.
- Simply Wall St.
What Is Amedisys, Inc.'s (NASDAQ:AMED) Share Price Doing?
Amedisys, Inc. (NASDAQ:AMED), which is in the healthcare business, and is based in United States, led the NASDAQGS...
- Zacks
Masimo (MASI) Introduces Pathway, Boosts Patient Monitoring
Masimo's (MASI) new feature, Pathway, is likely to help clinicians simplify their workflow associated with newborn resuscitation, thereby improving patient monitoring.
- Zacks
Has Amedisys (AMED) Outpaced Other Medical Stocks This Year?
Is (AMED) Outperforming Other Medical Stocks This Year?
- Zacks
Here's Why You Should Hold on to Hill-Rom (HRC) Stock Now
Investors' optimism continues to be high on solid prospects of Hill-Rom Holdings (HRC).
